Rula Health, a behavioral health company focused on improving access to mental healthcare, today announced a…
Author: admin
Function Health Expands Nationwide with Roll Out into New York and New Jersey
Function Health, a revolutionary health management platform empowering people to live 100 healthy years, today announced…
Yesoul Launches T1M PLUS Treadmill with Free & Unlimited Streaming and FunCardio for Ultimate Home Fitness
Yesoul, a rising star in the exercise equipment world, is thrilled to announce the launch of…
Women’s Health PAC (WHPAC), The First Bipartisan Women’s Health Political Action Committee (PAC), Funds More Than 15 Candidates
Today, the Women’s Health Political Action Committee (WHPAC) is proud to announce its funding of 16 candidates for…
Regenerative Orthopedics & Sports Medicine Announces Major Partnership for Groundbreaking Stem Cell Research
Regenerative Orthopedics & Sports Medicine (ROSM) is proud to announce a significant partnership with Orthobiologics Research…
LCISD Bolsters Campus Security with Athena Weapons Detection System, Embraces Evasion Detection Technology
Lamar Consolidated Independent School District (LCISD) recently updated its security with a new hi-tech addition: Weapons…
ADVANCED NANOTHERAPIES ANNOUNCES POSITIVE RESULTS IN ITS FIRST-IN-HUMAN TRIAL AND PLANS FOR U.S. EARLY FEASIBILITY STUDY FOR SIRPLUX™ DUO DRUG-COATED BALLOON
Advanced NanoTherapies (ANT), a clinical-stage medical device company committed to solving the most significant challenges in vascular…
Patient Files Civil Suit Against Erlanger Health and Dr. Thomas V. Clayton Alleging Sexual Abuse and Negligence
Andreozzi + Foote, a leading law firm specializing in the representation of victims of institutional abuse,…
FLORIDA SOUTHERN COLLEGE RECEIVES SACSCOC APPROVAL FOR MASTER OF SCIENCE IN PSYCHIATRIC-MENTAL HEALTH NURSE PRACTITIONER PROGRAM FOR JANUARY 2025
The Ann Blanton Edwards School of Nursing and Health Sciences at Florida Southern College has received approval from…
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Oct. 23, 2024, the company approved non-statutory stock options…